Cetuximab biosimilar (AMPO Biotechnology)
西妥昔单抗生物类似药（佛山安普泽生物）
Report date: 2025/08/11 10:10:35
Base Information
Drug NameCetuximab biosimilar (AMPO Biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesAmpo Biotechnology Inc
China Registration ClassN/A
Develop Information
Active CompaniesAmpo Biotechnology Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A